Accessibility Tools

Skip to main content
Central and East European Oncology Group
Central and East European Oncology Group
Together for better cancer treatment

CEEOG performs investigator-initiated phase II clinical studies and participates in large phase III trials carried out within international consortia. The main Group focus is breast cancer. CEEOG is a member of Breast International Group (BIG) and has been participating in pivotal BIG studies.

Central and East European Oncology Group
Together for better cancer treatment

CEEOG performs investigator-initiated phase II clinical studies and participates in large phase III trials carried out within international consortia. The main Group focus is breast cancer. CEEOG is a member of Breast International Group (BIG) and has been participating in pivotal BIG studies.

CEEOG - Central and East European Oncology Group


The Central and East European Oncology Group (CEEOG) was established in 1983, initially as the South and East European Oncology Group (SEEOG). At the time, SEEOG comprised 15 institutions from Bulgaria, Czechoslovakia, Hungary, Poland, Romania and Yugoslavia. Over the first 16 years, the Group was chaired by Prof. Sandor Eckhardt from the National Cancer Institute in Budapest. SEEOG was then the only drug-oriented cancer research organization in the region. In the 1980s and 1990s, the Group conducted translational studies and phase II and III clinical trials in breast, ovarian, lung, and head and neck cancer patients.

ABOUT US

Established in

Academic and community hospitals 

Countries

CEEOG publications

Projects 

Partners

Cooperation

Our Key Projects

Our Projects